000 01274 a2200349 4500
005 20250517165545.0
264 0 _c20180814
008 201808s 0 0 eng d
022 _a1744-8301
024 7 _a10.2217/fon-2017-0085
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFusi, Alberto
245 0 0 _aThe importance for immunoregulation for long-term cancer control.
_h[electronic resource]
260 _bFuture oncology (London, England)
_cAug 2017
300 _a1619-1632 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Immunological
_xpharmacology
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBiomarkers, Tumor
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aImmunomodulation
_xdrug effects
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aTreatment Outcome
700 1 _aDalgleish, Angus
773 0 _tFuture oncology (London, England)
_gvol. 13
_gno. 18
_gp. 1619-1632
856 4 0 _uhttps://doi.org/10.2217/fon-2017-0085
_zAvailable from publisher's website
999 _c27434493
_d27434493